참고문헌 (29)

1. 1 Global Strategy for Asthma Management and Prevention . Global Initiative for Asthma report , March 2017 Available at http://www.ginasthma.org . 

2. 2 Wenzel SE . Asthma phenotypes: the evolution from clinical to molecular approaches . Nat Med . 2012 ; 18 : 716 ‐ 725 . 22561835 

   상세보기

3. 3 Björck T , Dahlén SE . Leukotrienes and histamine mediate IgE‐dependent contractions of human bronchi: pharmacological evidence obtained with tissues from asthmatic and non‐asthmatic subjects . Pulm Pharmacol . 1993 ; 6 : 87 ‐ 96 . 8477156 

   상세보기

4. 4 Stone KD , Prussin C , Metcalfe DD . IgE, mast cells, basophils, and eosinophils . J Allergy Clin Immunol . 2010 ; 125 : S73 ‐ S80 . 20176269 

   상세보기

5. 5 Wills‐Karp M , Luyimbazi J , Xu X , et al. Interleukin‐13: central mediator of allergic asthma . Science . 1998 ; 282 : 2258 ‐ 2261 . 9856949 

   상세보기

6. 6 Zhang DH , Yang L , Cohn L , et al. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant‐negative mutant of GATA‐3 . Immunity . 1999 ; 11 : 473 ‐ 482 . 10549629 

   상세보기

7. 7 Schulman ES . Development of a monoclonal anti‐immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders . Am J Respir Crit Care Med . 2001 ; 164 ( suppl 1 ): S6 ‐ S11 . 11704611 

8. 8 Busse W , Corren J , Lanier BQ , et al. Omalizumab, anti‐IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma . J Allergy Clin Immunol . 2001 ; 108 : 184 ‐ 190 . 11496232 

   상세보기

9. 9 Chang TW , Shiung YY . Anti‐IgE as a mast cell‐stabilizing therapeutic agent . J Allergy Clin Immunol . 2006 ; 117 : 1203 ‐ 1212 . 16750976 

   상세보기

10. 10 Garrett JK , Jameson SC , Thomson B , et al. Anti‐interleukin‐5 (mepolizumab) therapy for hypereosinophilic syndromes . J Allergy Clin Immunol . 2004 ; 113 : 115 ‐ 119 . 14699394 

    상세보기

11. 11 Corren J , Weinstein S , Janka L , et al. Phase 3 study of reslizumab in patients with poorly controlled asthma: effects across a broad range of eosinophil counts . Chest . 2016 ; 150 : 799 ‐ 810 . 27018175 

12. 12 Wenzel S , Castro M , Corren J , et al. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium‐to‐high‐dose inhaled corticosteroids plus a long‐acting β2 agonist: a randomised double‐blind placebo‐controlled pivotal phase 2b dose‐ranging trial . Lancet . 2016 ; 388 : 31 ‐ 44 . 27130691 

13. 13 Yu X , Harden K , Gonzalez LC , et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells . Nat Immunol . 2009 ; 10 : 48 ‐ 57 . 19011627 

    상세보기

14. 14 Joller N , Hafler JP , Brynedal B , et al. Cutting edge: TIGIT has T cell‐intrinsic inhibitory functions . J Immunol . 2011 ; 186 : 1338 ‐ 1342 . 21199897 

    상세보기

15. 15 Joller N , Lozano E , Burkett PR , et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses . Immunity . 2014 ; 40 : 569 ‐ 581 . 24745333 

    상세보기

16. 16 Kourepini E , Paschalidis N , Simoes DC , et al. TIGIT enhances antigen‐specific Th2 recall responses and allergic disease . J Immunol . 2016 ; 196 : 3570 ‐ 3580 . 27016609 

    상세보기

17. 17 Wilson CN . Adenosine receptors and asthma in humans . Br J Pharmacol . 2008 ; 155 : 475 ‐ 486 . 18852693 

    상세보기

18. 18 Polosa R , Blackburn MR . Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease . Trends Pharmacol Sci . 2009 ; 30 : 528 ‐ 535 . 19762093 

    상세보기

19. 19 Barnes PJ . Theophylline . Am J Respir Crit Care Med . 2013 ; 188 : 901 ‐ 906 . 23672674 

    상세보기

20. 20 Tsutsui S , Schnermann J , Noorbakhsh F , et al. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis . J Neurosci . 2004 ; 24 : 1521 ‐ 1529 . 14960625 

    상세보기

21. 21 Schmidt DT , Watson N , Dent G , et al. The effect of selective and non‐selective phosphodiesterase inhibitors on allergen‐ and leukotriene C 4 ‐induced contractions in passively sensitized human airways . Br J Pharmacol . 2000 ; 131 : 1607 ‐ 1618 . 11139438 

    상세보기

22. 22 Calverley PM , Rabe KF , Goehring UM , et al. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials . Lancet . 2009 ; 374 : 685 ‐ 694 . 19716960 

23. 23 Youm J , Lee H , Chang HB , et al. Justicia procumbens extract (DW2008) selectively suppresses Th2 cytokines in splenocytes and ameliorates ovalbumin‐induced airway inflammation in a mouse model of asthma . Biol Pharm Bull . 2017 ; 40 : 1416 ‐ 1422 . 28867724 

    상세보기

24. 24 Van den Broeck W , Derore A , Simoens P . Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB/cAnNCrl mice . J Immunol Methods . 2006 ; 312 : 12 ‐ 19 . 16624319 

    상세보기

25. 25 Anderson AC , Joller N , Kuchroo VK . Lag‐3, Tim‐3, and TIGIT co‐inhibitory receptors with specialized functions in immune regulation . Immunity . 2016 ; 44 : 989 ‐ 1004 . 27192565 

    상세보기

26. 26 Lloyd CM , Hawrylowicz CM . Regulatory T cells in asthma . Immunity . 2009 ; 31 : 438 ‐ 449 . 19766086 

    상세보기

27. 27 Ryanna K , Stratigou V , Safinia N , et al. Regulatory T cells in bronchial asthma . Allergy . 2009 ; 64 : 335 ‐ 347 . 19220222 

    상세보기

28. 28 Tao JH , Cheng M , Tang JP , et al. Foxp3, regulatory T cell, and autoimmune diseases . Inflammation . 2017 ; 40 : 328 ‐ 339 . 27882473 

    상세보기

29. 29 Yoon J , Lee H , Chang HB , et al. DW1029M, a novel botanical drug candidate, inhibits advanced glycation end‐product formation, rat lens aldose reductase activity, and TGF‐β1 signaling . Am J Physiol Renal Physiol . 2014 ; 306 : F1161 ‐ F1170 . 24694590